MDGL logo

MDGL
Madrigal Pharmaceuticals Inc

6,864
Mkt Cap
$10.85B
Volume
338,615.00
52W High
$615.00
52W Low
$265.00
PE Ratio
-36.72
MDGL Fundamentals
Price
$470.50
Prev Close
$463.42
Open
$475.69
50D MA
$543.88
Beta
0.87
Avg. Volume
359,572.30
EPS (Annual)
-$21.90
P/B
17.33
Rev/Employee
$341,160.98
Loading...
Loading...
News
all
press releases
Federated Hermes Inc. Takes Position in Madrigal Pharmaceuticals, Inc. $MDGL
Federated Hermes Inc. bought a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
New York State Common Retirement Fund Grows Position in Madrigal Pharmaceuticals, Inc. $MDGL
New York State Common Retirement Fund increased its stake in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 13.4% in the third quarter, according to the company in its most...
MarketBeat·8d ago
News Placeholder
Madrigal Pharmaceuticals, Inc. $MDGL Shares Sold by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. decreased its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 28.3% in the 3rd quarter, according to the company in its most recent...
MarketBeat·9d ago
News Placeholder
Madrigal Pharmaceuticals (NASDAQ:MDGL) Now Covered by Barclays
Barclays assumed coverage on shares of Madrigal Pharmaceuticals in a research note on Tuesday. They set an "overweight" rating and a $964.00 target price on the stock...
MarketBeat·10d ago
News Placeholder
Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Sells 647 Shares of Stock
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Rebecca Taub sold 647 shares of the business's stock in a transaction that occurred on Monday, January 26th. The stock was sold...
MarketBeat·12d ago
News Placeholder
Madrigal Pharmaceuticals (NASDAQ:MDGL) Director Rebecca Taub Sells 647 Shares
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) Director Rebecca Taub sold 647 shares of the business's stock in a transaction on Monday, January 26th. The shares were sold at an...
MarketBeat·12d ago
News Placeholder
Insider Selling: Madrigal Pharmaceuticals (NASDAQ:MDGL) CEO Sells 1,577 Shares of Stock
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) CEO William John Sibold sold 1,577 shares of the firm's stock in a transaction on Monday, January 26th. The shares were sold at an...
MarketBeat·12d ago
News Placeholder
Carole Huntsman Sells 910 Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) insider Carole Huntsman sold 910 shares of the business's stock in a transaction that occurred on Monday, January 26th. The shares were...
MarketBeat·12d ago
News Placeholder
STVN or MDGL: Which Is the Better Value Stock Right Now?
STVN vs. MDGL: Which Stock Is the Better Value Option?
Zacks·13d ago
News Placeholder
Madrigal Pharmaceuticals, Inc. $MDGL Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH raised its position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Free Report) by 388.3% during the third quarter, according to the company in...
MarketBeat·13d ago
<
1
2
...
>

Latest MDGL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.